Metabolism of three pharmacologically active drugs in isolated human and rat hepatocytes: analysis of interspecies variability and comparison with metabolism in vivo.
1. The metabolism of the three drugs (Org GB 94, Org 3770 and Org OD 14) was studied in isolated human and rat hepatocytes. The metabolic profiles in rat and human hepatocytes were compared with the available in vivo data in both species. 2. All three drugs were metabolized extensively under the conditions used, both in human and rat hepatocytes, showing both extensive phase I and II metabolism. 3. During 3-h incubation with rat hepatocytes the three compounds were metabolized completely, whereas incubation with human hepatocytes only resulted in partial metabolism, amounting for 58% (Org GB 94), 36% (Org 3770) and 94% (Org OD 14) of the dose. In addition, rat hepatocytes excreted relatively more of the formed metabolites than human hepatocytes. 4. For both species, the metabolites formed in the isolated cells were quite similar to those found in vivo. With respect to Org GB 94 and Org 3770, metabolites were detected in man in vivo and in isolated human hepatocytes that were not found in any of the animal species studied previously. 5. The reflection of interspecies differences in isolated hepatocytes, with respect to both metabolite profiles and human-specific metabolites, renders isolated human hepatocytes a very valuable tool during preclinical drug development.
Sandker
G W
GW
Department of Pharmacology and Therapeutics, University Centre for Pharmacy, Groningen, The Netherlands.
Vos
R M
RM
Delbressine
L P
LP
Slooff
M J
MJ
Meijer
D K
DK
Groothuis
G M
GM
D045930:Anabolic Agents / Q000378:metabolism* / Q000493:pharmacokinetics; D000818:Animals; D000929:Antidepressive Agents, Tricyclic / Q000378:metabolism* / Q000493:pharmacokinetics; D001711:Biotransformation; D002470:Cell Survival / Q000502:physiology; D002478:Cells, Cultured; D003989:Dibenzoxazepines / Q000378:metabolism* / Q000493:pharmacokinetics; D006801:Humans; D008099:Liver / Q000166:cytology / Q000378:metabolism*; D008297:Male; D008803:Mianserin / Q000031:analogs & derivatives* / Q000378:metabolism / Q000493:pharmacokinetics; D000078785:Mirtazapine; D009652:Norpregnenes / Q000378:metabolism* / Q000493:pharmacokinetics; D051381:Rats; D017208:Rats, Wistar; D013045:Species Specificity
D045930:Anabolic Agents; D000929:Antidepressive Agents, Tricyclic; D003989:Dibenzoxazepines; D009652:Norpregnenes; C012636:Org GC 94; D008803:Mianserin; D000078785:Mirtazapine; C027385:tibolone